Hologic's 15min chart triggers KDJ Golden Cross, Bullish Marubozu pattern.

Hologic's 15-minute chart has recently triggered a Golden Cross in the KDJ indicator, accompanied by a Bullish Marubozu candlestick pattern at 08/29/2025 15:15. This suggests a shift in the momentum of the stock price towards the upside, indicating potential for further gains. As buyers continue to exert control over the market, it is likely that bullish momentum will persist.

Hologic's (HOLX) 15-minute chart has recently exhibited a notable technical signal, suggesting a potential shift in the stock's momentum towards the upside. On August 29, 2025, at 15:15, the chart displayed a Golden Cross in the KDJ indicator, accompanied by a Bullish Marubozu candlestick pattern. These signals indicate that buyers are currently in control of the market and that further price appreciation is likely.

The KDJ Golden Cross, a technical indicator, occurs when the K line crosses above the D line, often seen as a bullish signal indicating a potential shift in the stock's momentum towards the upside [1]. The Bullish Marubozu, characterized by a long body with no shadows above or below, suggests strong buying pressure driving the stock [1].

These signals follow a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in several other stocks, including ASGN and Cushing NextGen [2, 3]. While these technical indicators provide insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.

As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: - Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. - Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. - CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. - Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. - Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. - Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. - JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. - Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. - Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. - MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. - Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. - Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. - Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. - Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. - Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. - Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. - Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. - Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. - PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. - Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1]. Neutral Outlook: - Allegiant Travel (ALGT) was initiated with a Neutral rating by UBS Group, with a price target lowered from $60.00 to $59.00 [1]. - Alaska Air Group (ALK) was initiated with a Neutral rating and a $49.00 target by UBS Group [1]. - AvalonBay (AVB) was rated "Hold" by Evercore ISI with a price target of $229.00 [1]. - Benitec Biopharma (BNTC) was initiated with a "Buy" rating by TD Cowen [1]. - Broadridge Financial Solutions (BR) received a "Hold" rating from D.A. Davidson with a $220.00 target [1]. - Camden Property (CPT) was rated "Hold" by Evercore ISI with a price target of $124.00, implying a 13.26% upside [1]. - Citigroup (C) had a price target of $77.00 set by Evercore ISI, while Oppenheimer reiterated an "Outperform" rating [1]. - Coinbase Global (COIN) received a "Hold" rating from Goldman Sachs with a $268.00 price target [1]. - Coterra Energy (CTRA) was assigned a "Buy" rating by Barclays Capital with a $37.00 target [1]. - Crexendo (CXDO) was rated "Buy" at Northland Securities with a price target of $8.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - DoubleVerify (DV) had its "Buy" rating reiterated by Craig Hallum [1]. - Emerson Electric Company (EMR) was rated "Buy" by TD Cowen, with a price target of $150.00 [1]. - Enovix (ENVX) received a "Buy" rating from Northland Securities with a $25.00 target [1]. - Enterprise Products Partners (EPD) was initiated with a "Hold" rating and a $33.00 price target by TD Cowen [1]. - Equity Residential (EQR) was upgraded by Evercore ISI from In-Line to Outperform, with a new target of $75.00, up from $74.00 [1]. - EQT Corp. (EQT) was initiated with an Overweight rating and a $65.00 target by Barclays [1]. - Essex Property (ESS) was rated "Hold" by Evercore ISI with a price target of $296.00 [1]. - Essent Group (ESNT) was downgraded from Outperform to Market Perform by Keefe, Bruyette & Woods, with a price target of $67.00 [1]. - Expand Energy (EXE) received a "Buy" rating from Northland Securities with a $25.00 target [1]. - First Republic Bank (FRC) was downgraded by Jefferies from Overweight to Hold, with a price target of $24.00 [1]. - Fiserv (FISV) was upgraded by Raymond James from Market Perform to Outperform, with a new target of $180.00, up from $175.00 [1]. - Five Below (FIVE) was rated "Hold" by Wedbush with a price target of $140.00 [1]. - Flextronics International (FLEX) was initiated with a "Buy" rating by Northland Securities with a price target of $15.00 [1]. - Global Payments (GPAY) was rated "Buy" by TD Cowen with a price target of $120.00 [1]. - HCA Healthcare (HCA) was downgraded by Jefferies from Overweight to Hold, with a price target of $350.00 [1]. - Hologic (HOLX) was upgraded by Morgan Stanley from In-Line to Outperform, with a price target of $160.00 [1]. - Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. - MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [